Bent Jakobsen of Immunocore Ltd. in the United Kingdom, collaborating with Cardiff and Oxford Universities, will test whether a novel biologic therapy, engineered from immune cells, can clear virus from latently-infected HIV cells. If successful, the HIV-infected patients could control the disease without retroviral drugs.
Grant ID
OPP1025563
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False